2Goldstein HM, Wallace S, Anderson JH, et al. Transcatheter occlusion of abdominall tumors. Radiology, 1976; 120(3): 539-545.
3Kamada K, Nakanishi T, Kitamoto M, et al. Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipoidlo suspension and doxorubicin hydrochloride emulsion. J Vasc Interv Radiol, 2001; 12(7) : 847 - 854.
4O'Suilleabhain CB, Poon RT, Yong JL, et al. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg, 2003; 90(3): 325- 331.
5Barone M, Ettorre GC, Ladisa R, et al. Transcatheter arterial chemoembolization(TACE) in treatment of hepatocelluar carcinoma. Hepatogastroenterology, 2003; 50(49): 183-187.
6Yarnada R, Kishi K, Terada M, et al. Transcatheter arterial chemoembolization for unresectalbe hepatocellular carcinoma.Spring Verlag, 1992; 259 - 262.
7Lo CM, Ngan H, Tso WK. Randomized controlled trim of ransarterial lipiodol chemoembolization for unresectable hepatocellular carcinama. Hepatology, 2002; 35(5): 1164-1171.
8Gunji T, Kawauchi N, Akahane M, et al. Long-term outcome of transcatheter arterial chemoembolization with autologous blood clot for unresectalbe hepatocellular carcinoma. Int J Oncol, 2002; 21(2) : 427 - 432.
9Trinchet JC, Ganne-Carrie N, Beangrand M. Intraarterial chemoembolization in patients with hepaocellular carcinoma. Hepatogastro Enterology, 1998; 45(Suppl 3) : 1242 - 1243.
10Ochiai T, Sonoyama T, Hironaka T, et al. Hepatectomy with chemoembolization for treatment of hepatocellular carcinoma. Hepatogastroenterology, 2003 ; 50 (51 ) : 750 - 755.
